Skip to main content

Want a detailed portfolio tracker?

AZTA
NASDAQ
$26.26

Azenta Inc (AZTA)

Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies within the biotechnology and pharmaceutical industries. The company excels in innovative automation and comprehensive biorepository services, facilitating faster drug discovery while ensuring adherence to stringent regulatory standards. With a forward-looking strategy that leverages advanced storage technologies and strategic partnerships, Azenta is uniquely positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to pioneering scientific research through sophisticated innovations underscores its potential appeal to institutional investors seeking exposure in the dynamic life sciences sector.
Website: https://www.azenta.com
68 analysts
Buy
Target: $26.20 (-0.23%)

Market Cap

$1.23B

P/B Ratio

0.75

Revenue 5Y CAGR

+23.76%

Free Cash Flow Yield

2.44%

Price Chart

Valuation
Market Cap$1.23B
Forward P/E29.07
P/S2.06
P/B0.75
Profitability
Total Revenue (TTM)$596M
Gross Profit (TTM)$264M
EBITDA-$89M
Profit Margin-29.1%
Operating Margin-10.6%
EPS-$3.76
Financial Health
Free Cash Flow Yield2.44%
Growth & Risk
Revenue 5Y CAGR+23.76%
FCF 5Y CAGR-23.08%
Beta (5Y)1.32
Sharpe Ratio-0.05